
The global pharmaceutical industry continues to experience strong growth driven by innovation in biologics, oncology, diabetes and obesity treatment, vaccines, and rare disease therapies. In August 2026, Pharm Exec magazine published the 2026 Pharm Exec 50, ranking the Top 50 pharmaceutical companies worldwide by prescription drug (Rx) sales in fiscal year 2025.
This ranking is widely regarded as one of the most authoritative industry benchmarks, offering valuable insight for pharmaceutical manufacturers, API and packaging suppliers, pharmaceutical equipment companies, and distributors and contract manufacturing organizations (CMOs).
Below is the fully updated 2026 Global Top 50 Pharmaceutical Companies List, based on 2025 Rx sales.
Tabla de contenido
PalancaEsta clasificación refleja rendimiento comercial real, not market capitalization or valuation. Figures in the table are 2025 Rx sales, shown in US$ billion.
| Rango | Compañía | Sede | 2025 Rx sales (US$ billion) |
|---|---|---|---|
| 1 | Eli Lilly | EE.UU | 60.78 |
| 2 | Johnson & Johnson | EE.UU | 59.33 |
| 3 | Abbvie | EE.UU | 58.27 |
| 4 | roche | Suiza | 57.51 |
| 5 | AstraZeneca | Reino Unido | 55.04 |
| 6 | Merck & Co. (MSD) | EE.UU | 54.69 |
| 7 | Novartis | Suiza | 54.33 |
| 8 | Pfizer | EE.UU | 49.91 |
| 9 | sanofi | Francia | 48.97 |
| 10 | Bristol-Myers Squibb | EE.UU | 47.75 |
| 11 | Novo Nordisk | Dinamarca | 46.80 |
| 12 | GSK (GlaxoSmithKline) | Reino Unido | 42.72 |
| 13 | amgen | EE.UU | 34.95 |
| 14 | Takeda | Japón | 29.67 |
| 15 | Ciencias de Galaad | EE.UU | 28.83 |
| 16 | Boehringer-Ingelheim | Alemania | 23.82 |
| 17 | Bayer | Alemania | 19.19 |
| 18 | CSL | Australia | 15.44 |
| 19 | viatris | EE.UU | 14.09 |
| 20 | tevá | Israel | 14.08 |
| 21 | Astellas | Japón | 12.60 |
| 22 | Daiichi Sankyo | Japón | 12.04 |
| 23 | Farmacéutica Vértex | EE.UU | 11.97 |
| 24 | Grupo Sandoz | Suiza | 11.09 |
| 25 | Otsuka Holdings | Japón | 9.87 |
| 26 | Merck KGaA | Alemania | 9.73 |
| 27 | UCB | Bélgica | 8.24 |
| 28 | Grifols | España | 7.33 |
| 29 | biogeno | EE.UU | 7.12 |
| 30 | Farmacia del Sol | India | 6.44 |
| 31 | Regenerón | EE.UU | 6.31 |
| 32 | organon | EE.UU | 6.06 |
| 33 | Yunnan Baiyao | Porcelana | 5.72 |
| 34 | Abbott | EE.UU | 5.51 |
| 35 | servidor | Francia | 5.44 |
| 36 | Bausch Health | Canadá | 5.41 |
| 37 | BeOne Medicines (formerly BeiGene) | Suiza | 5.28 |
| 38 | Fresenius | Alemania | 5.21 |
| 39 | Shanghai Pharmaceuticals | Porcelana | 5.16 |
| 40 | Eisai | Japón | 4.78 |
| 41 | Sino Biopharmaceutical | Hong Kong | 4.37 |
| 42 | Menarini | Italia | 4.36 |
| 43 | incitar | EE.UU | 4.35 |
| 44 | Ipsen | Francia | 4.16 |
| 45 | argenx | Países Bajos | 4.15 |
| 46 | Farmacéutica Jazz | Irlanda | 4.02 |
| 47 | STADA | Alemania | 4.02 |
| 48 | Medicina Huadong | Porcelana | 3.97 |
| 49 | Medicina de Jiangsu Hengrui | Porcelana | 3.85 |
| 50 | Haleon | Reino Unido | 3.60 |
Data source: Pharm Exec, 2026 Pharm Exec 50 (FY 2025 prescription drug sales). Company names use common English forms; BeOne Medicines appears under its current name (formerly BeiGene).
The headline change this year is Eli Lilly’s jump from No. 11 in the previous ranking to No. 1, with about $60.8 billion in 2025 Rx sales, up roughly 49% year over year. Johnson & Johnson, last year’s leader, is now No. 2. AbbVie, Roche, and AstraZeneca complete the top five.
Fifteen companies in the Top 50 are headquartered in the United States, still the largest national group, with particular strength in oncology, immunology, biologics, and metabolic disease, including GLP-1 therapies.
Switzerland is represented by Roche, Novartis, Sandoz, and BeOne Medicines (formerly BeiGene, now listed with a Swiss headquarters). Japan remains well represented by Takeda, Astellas, Daiichi Sankyo, Otsuka, and Eisai. Germany includes Boehringer Ingelheim, Bayer, Merck KGaA, Fresenius, and STADA.
Five Chinese companies are in this year’s list if Sino Biopharmaceutical (Hong Kong) is included: Yunnan Baiyao, Shanghai Pharmaceuticals (a new entrant), Sino Biopharmaceutical, Huadong Medicine, and Jiangsu Hengrui Medicine. CSPC Pharmaceutical Group is no longer in the Top 50. From India, Sun Pharma remains on the list; Dr. Reddy’s Laboratories is not in this year’s Top 50. New global entrants also include argenx (Netherlands) and Haleon (UK).
If you are involved in pharmaceutical machinery manufacturing, packaging solutions (vials, bottles, blister, ampoules), API and excipient supply, or contract manufacturing (CDMO/CMO), this list directly reflects where purchasing power is concentrated, which companies control global drug production, and who your most valuable long-term customers may be.
Based on this ranking, the pharmaceutical industry will continue focusing on biologics and biosimilars, GLP-1 diabetes and obesity drugs, cancer immunotherapy, rare disease treatments, and personalized medicine. Companies at the top of the 2026 Pharm Exec 50 are expected to drive mergers and acquisitions, equipment upgrades, and new plant investments worldwide.
La mayoría de las empresas de este ranking realizan grandes operaciones de dosis sólidas orales (OSD) junto con productos biológicos. Sus plantas de tabletas y cápsulas están construidas alrededor de una cadena de proceso similar, y cada paso necesita equipos de grado GMP que produzcan lotes repetibles. Cubrimos esto en detalle en ¿Qué equipos utilizan las 50 principales empresas farmacéuticas del mundo para garantizar la calidad?.
| Paso del proceso | Objetivo | Equipos JIANPAI relacionados |
|---|---|---|
| Granulación húmeda | Densifique los polvos y mejore el flujo y la uniformidad del contenido. | Granuladores mezcladores de alto cizallamiento (JHZ-C, JHZ-D) |
| El secado | Reducir la humedad de los gránulos al nivel validado. | Secadores de lecho fluido (JFG-C) |
| Dimensionado y fresado | Controle el tamaño de las partículas antes de mezclar | Molinos farmacéuticos (Granulador de tamaño JZL) |
| Mezcla | Mezclar gránulos con lubricantes y excipientes. | Licuadoras farmacéuticas (Mezclador JPH de tres excentricidades) |
| Recubrimiento | Película, azúcar o recubrimiento entérico de tabletas. | Máquinas de recubrimiento de tabletas (JGB-D, JGB-E) |
| Líneas integradas | Líneas de granulación cerradas y enlazadas que reducen la manipulación manual | Línea de producción de granulación totalmente cerrada, fabricación continua |
Los fabricantes genéricos y contratados que suministran a estos líderes, o compiten con ellos, a menudo comparan sus propias líneas con los mismos estándares. Para la planificación del presupuesto, consulte nuestro Guía de precios de la máquina de recubrimiento de tabletas..
El 2026 Global Top 50 Pharmaceutical Companies Ranking provides a clear overview of the world’s leading drug manufacturers, based on 2025 prescription drug sales, and reflects the direction of the global pharmaceutical industry. From biologics and oncology to diabetes, obesity, and rare disease therapies, these top companies will continue to drive innovation, capacity expansion, and equipment upgrades worldwide.
Como fabricante profesional de maquinaria farmacéutica, Jianpai closely follows the development trends of these global pharma leaders and is committed to providing reliable, high-efficiency production and processing solutions for pharmaceutical manufacturers across the world. Whether you are planning a new production line, upgrading existing equipment, or expanding your formulation and packaging capacity, JIANPAI offers customized solutions to meet your exact needs.
Eli Lilly is No. 1 in the 2026 Pharm Exec 50, with about $60.8 billion in 2025 prescription (Rx) drug sales. Johnson & Johnson is No. 2. The complete Top 50 table above ranks companies by 2025 Rx sales, as described in the methodology section.
Large OSD plants typically run high shear wet granulation, fluid bed drying, milling and sizing, blending, tablet compression, and film or functional coating, often with closed material transfer and automated cleaning.
Top companies set the quality and compliance expectations that generic and contract manufacturers follow. Equipment that meets their GMP, data integrity and containment needs is increasingly expected across the industry.
JIANPAI suministra equipos de granulación, secado, molienda, mezcla y recubrimiento para plantas de dosificación de sólidos orales. Envíenos sus productos y capacidad objetivo para una propuesta de línea.
Correo electrónico: [email protected] | Teléfono: +86 577-86932456 | No. 989 Lingde Road, nuevo distrito de Oujiangkou, Wenzhou, Zhejiang, China